Literature DB >> 14715555

Antibody reactivity to Omp31 from Brucella melitensis in human and animal infections by smooth and rough Brucellae.

Juliana Cassataro1, Karina Pasquevich, Laura Bruno, Jorge C Wallach, Carlos A Fossati, Pablo C Baldi.   

Abstract

Group 3 of outer membrane proteins (OMPs) of Brucella includes Omp25 and Omp31, which share 34% identity. Omp25 is highly conserved in Brucella species, and Omp31 is present in all Brucella species, except Brucella abortus. Antibodies to Brucella melitensis Omp31 have been sought only in infected sheep, and Western blotting of sera from infected sheep did not reveal anti-Omp31 reactivity. We obtained recombinant purified Omp31 (B. melitensis) and tested its recognition by sera from humans and animals suffering from brucellosis by an indirect enzyme-linked immunosorbent assay (ELISA). Serum samples from 74 patients, 57 sheep, and 47 dogs were analyzed; brucellosis was confirmed by bacteriological isolation in all ovine and canine cases and 31 human cases of brucellosis. Thirty-five patients (47%) were positive for antibodies to Omp31, including seven cases of Brucella suis infection, two cases of B. abortus infection, and three cases of B. melitensis infection. Of 39 sheep naturally infected with B. melitensis (biovars 1 and 3), 23 (59%) were positive for antibodies to Omp31. Anti-Omp31 antibodies were also detected in 12 of 18 rams (67%) in which Brucella ovis was isolated from semen. Antibodies to Omp31 were also found in 41 (87%) of the 47 dogs, including 13 with recent infection. These results suggest that an indirect ELISA using recombinant purified Omp31 from B. melitensis would be of limited value for the diagnosis of human and animal brucellosis. Nevertheless, the potential usefulness of this antigen in combination with other recombinant proteins from Brucella should not be dismissed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715555      PMCID: PMC321362          DOI: 10.1128/cdli.11.1.111-114.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  11 in total

1.  Major outer membrane proteins of Brucella spp.: past, present and future.

Authors:  Axel Cloeckaert; Nieves Vizcaíno; Jean-Yves Paquet; Raúl A Bowden; Philip H Elzer
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

2.  Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay.

Authors:  J J Letesson; A Tibor; G van Eynde; V Wansard; V Weynants; P Denoel; E Saman
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

3.  DNA polymorphism at the omp-31 locus of Brucella spp.: evidence for a large deletion in Brucella abortus, and other species-specific markers.

Authors:  N Vizcaíno; J M Verger; M Grayon; M S Zygmunt; A Cloeckaert
Journal:  Microbiology (Reading)       Date:  1997-09       Impact factor: 2.777

4.  Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species.

Authors:  N Vizcaíno; R Kittelberger; A Cloeckaert; C M Marín; L Fernández-Lago
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

5.  Use of indirect enzyme-linked immunosorbent assay with hot saline solution extracts of a variant (M-) strain of Brucella canis for diagnosis of brucellosis in dogs.

Authors:  E M Mateu-de-Antonio; M Martín; M Soler
Journal:  Am J Vet Res       Date:  1993-07       Impact factor: 1.156

6.  Characterization of an immuno-dominant antigen in Brucella ovis and evaluation of its use in an enzyme-linked immunosorbent assay.

Authors:  R Kittelberger; D S Diack; N Vizcaíno; M S Zygmunt; A Cloeckaert
Journal:  Vet Microbiol       Date:  1998-01-16       Impact factor: 3.293

7.  Diagnosis of canine brucellosis by detection of serum antibodies against an 18 kDa cytoplasmic protein of Brucella spp.

Authors:  P C Baldi; M M Wanke; M E Loza; N Monachesi; C A Fossati
Journal:  Vet Microbiol       Date:  1997-09       Impact factor: 3.293

8.  Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein.

Authors:  N Vizcaíno; A Cloeckaert; M S Zygmunt; G Dubray
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

9.  Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay.

Authors:  A Cloeckaert; P de Wergifosse; G Dubray; J N Limet
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

10.  The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.

Authors:  Silvia M Estein; Juliana Cassataro; Nieves Vizcaíno; Michel S Zygmunt; Axel Cloeckaert; Raúl A Bowden
Journal:  Microbes Infect       Date:  2003-02       Impact factor: 2.700

View more
  22 in total

1.  Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.

Authors:  Juliana Cassataro; Silvia M Estein; Karina A Pasquevich; Carlos A Velikovsky; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

2.  Enzymatic and biological characteristics of enolase in Brucella abortus A19.

Authors:  Xiangan Han; Chan Ding; Hongjun Chen; Qinghai Hu; Shengqing Yu
Journal:  Mol Biol Rep       Date:  2011-06-15       Impact factor: 2.316

3.  A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.

Authors:  Juliana Cassataro; Carlos A Velikovsky; Silvia de la Barrera; Silvia M Estein; Laura Bruno; Raúl Bowden; Karina A Pasquevich; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Evaluation of indirect enzyme-linked immunosorbent assays and IgG avidity assays using a protein A-peroxidase conjugate for serological distinction between Brucella abortus S19-vaccinated and -infected cows.

Authors:  Ana C A M Pajuaba; Deise A O Silva; José R Mineo
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

5.  Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.

Authors:  Maria Clausse; Alejandra G Díaz; Andrés E Ibañez; Juliana Cassataro; Guillermo H Giambartolomei; Silvia M Estein
Journal:  Clin Vaccine Immunol       Date:  2014-10-22

6.  Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides.

Authors:  Purushottam Kaushik; Dhirendra K Singh; S Vinoth Kumar; Ashok K Tiwari; Gunjan Shukla; Shanker Dayal; Pallav Chaudhuri
Journal:  Vet Res Commun       Date:  2009-12-16       Impact factor: 2.459

7.  Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.

Authors:  Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

8.  VirB12 is a serological marker of Brucella infection in experimental and natural hosts.

Authors:  Hortensia G Rolán; Andreas B den Hartigh; Melissa Kahl-McDonagh; Thomas Ficht; L Garry Adams; Renée M Tsolis
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

9.  Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.

Authors:  Juliana Cassataro; Carlos A Velikovsky; Laura Bruno; Silvia M Estein; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

10.  Efficient Immunization of BALB/c Mice against Pathogenic Brucella melitensis and B. ovis: Comparing Cell-Mediated and Protective Immune Responses Elicited by pCDNA3.1 and pVAX1 DNA Vaccines Coding for Omp31 of Brucella melitensis.

Authors:  Naser Harzandi; Haniyeh Aghababa; Nima Khoramabadi; Termeh Tabaraie
Journal:  Iran J Biotechnol       Date:  2021-01-01       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.